Dunger D B, Leonard J V, Preece M A
Arch Dis Child. 1984 Jul;59(7):657-60. doi: 10.1136/adc.59.7.657.
Longitudinal growth data from 31 patients with hepatic glycogen storage disease (type I (8 patients), type Ib (three patients), type III (13 patients), and type IX (phosphorylase kinase deficiency) (7 patients) ) have been reviewed. All patients were below the mean for height at presentation; the mean height standard deviation scores were -2.13 (type I), -2.0 (type Ib), -2.4 (type III), and -1.6 (type IX). Untreated, most patients with type I and Ib grew slowly with no catch up growth but three patients with mild disease grew normally. Most children with type III disease grew at a normal velocity throughout childhood. Puberty was delayed and final height normal. Some of the children with type III and all of those with type IX had catch up growth throughout childhood. Intensive treatment of patients with severe forms of type I and Ib disease resulted in catch up growth, but this was not complete if the treatment was started late.
回顾了31例肝糖原贮积病患者(I型(8例)、Ib型(3例)、III型(13例)和IX型(磷酸化酶激酶缺乏症)(7例))的纵向生长数据。所有患者初诊时身高均低于平均水平;平均身高标准差分数分别为:I型-2.13、Ib型-2.0、III型-2.4、IX型-1.6。未经治疗时,大多数I型和Ib型患者生长缓慢,无追赶生长,但3例轻症患者生长正常。大多数III型疾病患儿在整个儿童期生长速度正常。青春期延迟,最终身高正常。一些III型患儿和所有IX型患儿在整个儿童期有追赶生长。对严重的I型和Ib型疾病患者进行强化治疗可导致追赶生长,但如果治疗开始得晚,则追赶生长不完全。